What is Spravato?

Spravato (esketamine) is a groundbreaking treatment designed for individuals with treatment-resistant depression (TRD) and major depressive disorder (MDD) accompanied by acute suicidal thoughts or behaviors. Unlike traditional antidepressants, Spravato, administered as a nasal spray under professional supervision, targets the NMDA receptor in the brain, offering rapid relief for patients who have not found success with other therapies.

At our practice, Dr. Henry Schulte and Dr. Browder provide tailored Spravato treatments. We begin with a thorough evaluation to ensure Spravato is the right choice for your needs. The treatment is conducted in a comfortable, controlled setting where we monitor for any potential side effects, prioritizing your safety throughout the process.

FDA-approved and typically used alongside an oral antidepressant, Spravato treatment involves regular sessions, determined by the provider, where patients administer the nasal spray in our office and stay for 2 hours under observation and support.

We accept BCBS, Aetna, and UHC (Optum) commercial insurance plans to facilitate access to this innovative treatment. If traditional treatments haven’t worked for you, Spravato could be a viable option. Contact us at 480-941-9004 or email us at admin@drhjimschulte.com to schedule a consultation and explore how this advanced treatment might benefit you.

**Please Note: Coverage is not guaranteed and will be determined through the prior authorization process.

For more information about Spravato please visit the following website:

www.spravato.com